About University of California at Los Angeles UCLA Tiverton
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of California at Los Angeles UCLA Tiverton
During the past decade, University of California at Los Angeles UCLA Tiverton conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of California at Los Angeles UCLA Tiverton
According to Clinical.Site data, the most researched conditions in "University of California at Los Angeles UCLA Tiverton" are
"Cushing's Disease" (2 trials). Many other conditions were trialed in "University of California at Los Angeles UCLA Tiverton" in a lesser frequency.
Clinical Trials Intervention Types at University of California at Los Angeles UCLA Tiverton
Most popular intervention types in "University of California at Los Angeles UCLA Tiverton" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pasireotide sub-cutaneous" (1 trials), "SOM230 LAR 10 mg" (1 trials), "SOM230 LAR 30 mg" (1 trials) and "pasireotide LAR" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of California at Los Angeles UCLA Tiverton
The vast majority of trials in "University of California at Los Angeles UCLA Tiverton" are
2 trials for "All" genders.
Clinical Trials Status at University of California at Los Angeles UCLA Tiverton
Currently, there are NaN active trials in "University of California at Los Angeles UCLA Tiverton".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University of California at Los Angeles UCLA Tiverton,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of California at Los Angeles UCLA Tiverton, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".